Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 565

1.

Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.

Portenoy RK, Farrar JT, Backonja MM, Cleeland CS, Yang K, Friedman M, Colucci SV, Richards P.

Clin J Pain. 2007 May;23(4):287-99.

PMID:
17449988
3.

Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation.

Roth SH, Fleischmann RM, Burch FX, Dietz F, Bockow B, Rapoport RJ, Rutstein J, Lacouture PG.

Arch Intern Med. 2000 Mar 27;160(6):853-60.

PMID:
10737286
4.

Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain.

Citron ML, Kaplan R, Parris WC, Croghan MK, Herbst LH, Rosenbluth RJ, Reder RF, Slagle NS, Buckley BJ, Kaiko RF.

Cancer Invest. 1998;16(8):562-71.

PMID:
9844616
5.

Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study.

Silvestri B, Bandieri E, Del Prete S, Ianniello GP, Micheletto G, Dambrosio M, Sabbatini G, Endrizzi L, Marra A, Aitini E, Calorio A, Garetto F, Nastasi G, Piantedosi F, Sidoti V, Spanu P.

Clin Drug Investig. 2008;28(7):399-407.

PMID:
18544000
6.

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial.

Gimbel JS, Richards P, Portenoy RK.

Neurology. 2003 Mar 25;60(6):927-34.

PMID:
12654955
8.

Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?

Salzman RT, Roberts MS, Wild J, Fabian C, Reder RF, Goldenheim PD.

J Pain Symptom Manage. 1999 Oct;18(4):271-9.

PMID:
10534967
10.

Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain.

Pan H, Zhang Z, Zhang Y, Xu N, Lu L, Dou C, Guo Y, Wu S, Yue J, Wu D, Dai Y.

Clin Drug Investig. 2007;27(4):259-67.

PMID:
17358098
12.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
13.
14.

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy.

Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J.

Pain. 2003 Sep;105(1-2):71-8.

PMID:
14499422
16.

Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain.

Hale ME, Fleischmann R, Salzman R, Wild J, Iwan T, Swanton RE, Kaiko RF, Lacouture PG.

Clin J Pain. 1999 Sep;15(3):179-83.

PMID:
10524470
17.
19.

Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study.

Afilalo M, Etropolski MS, Kuperwasser B, Kelly K, Okamoto A, Van Hove I, Steup A, Lange B, Rauschkolb C, Haeussler J.

Clin Drug Investig. 2010;30(8):489-505. doi: 10.2165/11533440-000000000-00000.

PMID:
20586515
20.

Supplemental Content

Support Center